StockData
DataMeds AI, Inc. logo

DataMeds AI, Inc. (MEDS) stock

MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.74+0.10 (+15.41%)

Close on Nov 18, 2026Market cap $2.26MP/E –Yield –

DataMeds AI operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

DataMeds AI's operating cash flow for the twelve months ending Sep 30, 2026 was -$15.50M. For fiscal 2025 it was -$10.86M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.86M–
FY2024Dec 31, 2024-$1.22M–
FY2023Dec 31, 2023-$349.14K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$2.90M–
Q2 FY2026Jun 30, 2026-$2.89M–
Q1 FY2026Mar 31, 2026-$3.41M–
Q4 FY2025Dec 31, 2025-$6.29M–
Q3 FY2025Sep 30, 2025-$1.14M-209.4%
Q2 FY2025Jun 30, 2025-$2.08M-730.1%
Q1 FY2025Mar 31, 2025-$1.35M-4413.6%
Q4 FY2024Dec 31, 2024-$2.62M–
Q3 FY2024Sep 30, 2024$1.04M–
Q2 FY2024Jun 30, 2024$329.96K–
Q1 FY2024Mar 31, 2024$31.24K–

More DataMeds AI figures

See a number that looks wrong?